Skip to main content

Author: Vittoria Valentine

Algorithmic Process Optimization (APO) for Pharmaceutical Development.

2025 Data Science and Modeling for Green Chemistry Award

The Merck and Sunthetics team, consisting of Kevin Stone, Daniela E. Blanco, Kaitlyn Brinza, Melodie Christensen, Shane Grosser, Yasser Khelalef, Abderrahman Lazizi, Andy Liaw, Spencer McMinn, Rafik Oulbsir, Victor Schultz, Ethan Tenison, César A. Urbina-Blanco, Ajit Vikram, and Yuting Xu, is awarded for their work, “Algorithmic Process Optimization (APO) for Pharmaceutical Development.” This technology makes use of state-of-the-art approaches in active learning, including Bayesian Optimization, to locate global optima in complex operational spaces that are expensive to evaluate experimentally. The Merck and Sunthetics team developed and demonstrated the APO technology allows for sustainable process design by minimizing material use and selecting non-toxic reagents, translating into reductions of the drug development costs. APO’s versatility allows it to tackle numeric, discrete, and mixed-integer optimization problems with at least 11 input parameters, supporting both serial and parallel experimentation. Its ability to handle multi-objective optimizations focusing on cost and material efficiency with notable performance shows promise for AI-powered design for optimized and more sustainable processes.

Merck and Sunthetics

More about the Award

The Data Science and Modeling for Green Chemistry Award aims to recognize the research and development of computational tools that guide the design of sustainable chemical processes and the execution of green chemistry that demonstrates compelling environmental, safety, and efficiency improvements over current technologies in the pharmaceutical industry and its allied industrial partners.

This annual award is presented at the Green Chemistry & Engineering Confernece where presenters are invited to share their innovations. 

Continue reading

Recombinant DNA technology and chimeric protein expression for sustainable production of therapeutic peptides by microbial fermentation

2025 CMO Excellence in Green Chemistry Award

Olon S.p.A is awarded on their innovative work, “Recombinant DNA technology and chimeric protein expression for sustainable production of therapeutic peptides by microbial fermentation.” Leveraging their expertise in microbial fermentation, Olon S.p.A. has developed a flexible manufacturing platform for the synthesis of peptide therapeutics. This novel technology synthesizes peptides using microbial fermentation (rDNA expression), leading to reduced solvent and toxic material usage, as well as minimizing excess building blocks by using no protecting groups. This improves the overall PMI compared to the existing Solid Phase Peptide Synthesis (SPPS) methods. Moreover, as part of their platform, a Master Cell Bank (MCB) significantly reduces the lead time for manufacturing since the cells can be logarithmically proliferated to maximize the yield of desired product in the fermenter. They are adapting their novel Fermentation Platform towards commercial GLP-1 peptides and non-GLP-1 peptides. Olon’s novel Fermentation Platform can help address the growing global demand for peptide therapeutics while employing the principles of green chemistry. The team consists of Piera Fonte, Gian Luca Bertetti, Antonella Malcangi, Alberto Oppedisano, Mattia Stucchi, Marianna Lembo, Guido Trione, Eleonora Amante, Giuseppe Borrelli, and Giuseppe Ferrante.

Olon

More about the Award

The CMO Excellence in Green Chemistry Award seeks to recognize outstanding efforts by CMO companies in pharmaceutical green chemistry in support of pharmaceutical research, development and manufacturing that demonstrate compelling environmental, safety and/or efficiency improvements.

This annual award is presented at the Green Chemistry & Engineering Confernece where presenters are invited to share their innovations. 

Continue reading

From Bottleneck to Breakthrough: Developing a Sustainable and Scalable Manufacturing Process for a Complex ADC Drug-Linker

2025 Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry

The Merck team, consisting of Patrick Fier, Patrick Moon, Scott McCann, Tao Liang, Greg Estrada, Marc Poirier, Reed Larson, Lu Wang, Gao Shang, and Fuh-Rong Tsay, received this award for their work, “From Bottleneck to Breakthrough: Developing a Sustainable and Scalable Manufacturing Process for a Complex ADC Drug-Linker”. They demonstrated the impact of applying green chemistry principles in the manufacturing process of the linker for the antibody-drug conjugate (ADC) Sacituzumab tirumotecan (MK-2870). Originally, the manufacturing process had long lead times due to the 20-step synthetic sequence and faced a major bottleneck with the final purification that limited production to less than 100 g per month even with 24/7 operation in a high-potency chromatography suite. Major improvements were achieved by developing a synthesis from a widely available natural product that cut seven potent steps down to three. The Process Mass Intensity (PMI) was reduced by approximately 75%, and the amount of energy-intensive chromatography time was decreased by >99% compared to the original route. This work highlights the advantages of investing in greener and more sustainable processes that naturally improve the global supply of medicines to patients.

Merck

More about the Award

The Peter J. Dunn Award, established in 2016, recognizes outstanding industrial implementation of novel green chemistry and/or engineering in the pharmaceutical industry that demonstrates compelling environmental, safety, cost, and/or efficiency improvements over current technologies.

This annual award is presented at the Green Chemistry & Engineering Conference, where presenters are invited to share their innovations. 

Continue reading

A Sustainably-Designed Manufacturing Process to Adavelt™ Active from Renewable Feedstocks.

2025 Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry

Corteva

Corteva’s winning submission “A Sustainably-Designed Manufacturing Process to Adavelt™ Active from Renewable Feedstocks.” The Corteva team demonstrated the design of an efficient manufacturing process for Adavelt™ active, with sustainability as a core focus. They adopted green chemistry principles to maximize yield, reduce waste, and deliver a cost-effective solution for farmers. Building upon the first-generation supply route, they developed a process that eliminated three protecting groups, four steps, the use of precious metals, and replaced undesirable reagents with greener alternatives while producing an active ingredient effective against 20 diseases in over 30 crops.

More about the Award

The Peter J. Dunn Award, established in 2016, recognizes outstanding industrial implementation of novel green chemistry and/or engineering in the pharmaceutical industry that demonstrates compelling environmental, safety, cost, and/or efficiency improvements over current technologies.

This annual award is presented at the Green Chemistry & Engineering Conference, where presenters are invited to share their innovations. 

Continue reading